S. Lakhani, I. Ellis, and S. Schnitt, WHO Classification of Tumours of the Breast IARC: Lyon 2012 Estimation nationale de l'incidence et de la mortalité par cancer en France entre Disponible sur: http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies- chroniques-et-traumatismes, 1980.

C. Early-breast, M. Trialists-'collaborative-group-clarke, R. Collins, and S. Darby, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond Engl, vol.365, issue.9472, pp.1687-717, 2005.

P. Bedard, F. Cardoso, and M. Piccart-gebhart, Stemming Resistance to HER-2 Targeted Therapy, Journal of Mammary Gland Biology and Neoplasia, vol.104, issue.Suppl 3, pp.55-66, 2009.
DOI : 10.1007/s10911-009-9116-x

C. Elston and I. Ellis, pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.403-413, 1991.
DOI : 10.1016/0277-5379(88)90171-X

D. Flagiello, M. Gerbault-seureau, and X. Sastre-garau, Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer, Genes, Chromosomes and Cancer, vol.76, issue.4, pp.300-306, 1998.
DOI : 10.1002/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.0.CO;2-N

R. Natrajan, M. Lambros, and S. Rodríguez-pinilla, Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers, Clinical Cancer Research, vol.15, issue.8, pp.2711-2733, 2009.
DOI : 10.1158/1078-0432.CCR-08-1878

R. Natrajan, M. Lambros, and F. Geyer, Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?, Genes, Chromosomes and Cancer, vol.10, issue.4, pp.351-65, 2009.
DOI : 10.1002/gcc.20646

M. Bärlund, M. Tirkkonen, and F. Forozan, Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions, Genes, Chromosomes and Cancer, vol.56, issue.4, pp.372-378, 1997.
DOI : 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO;2-Z

P. Simpson, J. Reis-filho, and T. Gale, Molecular evolution of breast cancer, The Journal of Pathology, vol.189, issue.2, pp.248-54, 2005.
DOI : 10.1002/path.1691

L. Loo, D. Grove, and E. Williams, Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes, Cancer Research, vol.64, issue.23, pp.8541-8550, 2004.
DOI : 10.1158/0008-5472.CAN-04-1992

C. Perou, T. Sørlie, and M. Eisen, Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-52, 2000.
DOI : 10.1038/35021093

T. Sørlie, C. Perou, and R. Tibshirani, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10869-74, 2001.
DOI : 10.1073/pnas.191367098

C. Curtis, S. Shah, and S. Chin, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, issue.7403, pp.346-52, 2012.
DOI : 10.1038/nature10983

D. Koboldt, R. Fulton, and M. Mclellan, Comprehensive molecular portraits of human breast tumours, Nature, vol.16, issue.7418, pp.61-70, 2012.
DOI : 10.1038/nature11412

A. Goldhirsch, W. Wood, and A. Coates, Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Annals of Oncology, vol.22, issue.8, pp.1736-1783, 2011.
DOI : 10.1093/annonc/mdr304

T. Nielsen, F. Hsu, and K. Jensen, Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma, Clinical Cancer Research, vol.10, issue.16, pp.5367-74, 2004.
DOI : 10.1158/1078-0432.CCR-04-0220

M. Laakso, N. Loman, and A. Borg, Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors, Modern Pathology, vol.3, issue.10, pp.1321-1329, 2005.
DOI : 10.1038/modpathol.3800456

F. Mertens, C. Antonescu, and P. Hohenberger, Translocation-Related Sarcomas, Seminars in Oncology, vol.36, issue.4, pp.312-335, 2009.
DOI : 10.1053/j.seminoncol.2009.06.004

C. Fletcher, J. Bridge, and P. Hogendoorn, WHO Classification of Tumours of Soft Tissue and Bone, 2013.

S. Swerdlow, E. Campo, L. Harris, and N. , WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008.

C. Brenner, J. Chinnaiyan, and A. , Translocations in epithelial cancers, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1796, issue.2, pp.201-216, 2009.
DOI : 10.1016/j.bbcan.2009.04.005

M. Qi, Y. Li, and J. Liu, Morphologic Features of Carcinomas With Recurrent Gene Fusions, Advances In Anatomic Pathology, vol.19, issue.6, pp.417-441, 2012.
DOI : 10.1097/PAP.0b013e318273baae

R. Delellis, R. Lloyd, and P. Heitz, WHO Classification of Tumors of Endocrine Organs, 2004.

S. Tomlins, D. Rhodes, and S. Perner, Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer, Science, vol.310, issue.5748, pp.644-652, 2005.
DOI : 10.1126/science.1117679

C. Kumar-sinha, S. Tomlins, and A. Chinnaiyan, Recurrent gene fusions in prostate cancer, Nature Reviews Cancer, vol.10, issue.7, pp.497-511, 2008.
DOI : 10.1038/nrc2402

J. Eble, G. Sauter, and J. Epstein, WHO Classification of Tumours of the Urinary System and Male Genital Organs, 2004.

M. Bos, M. Gardizi, and H. Schildhaus, Activated RET and ROS: two new driver mutations in lung adenocarcinoma, Transl Lung Cancer Res, vol.2, issue.2, pp.112-133, 2013.

R. Mcdivitt and F. Stewart, Breast Carcinoma in Children, JAMA: The Journal of the American Medical Association, vol.195, issue.5, pp.388-90, 1966.
DOI : 10.1001/jama.1966.03100050096033

F. Tavassoli and H. Norris, Secretory carcinoma of the breast, Cancer, vol.375, issue.9, pp.2404-2417, 1980.
DOI : 10.1002/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8

P. Rosen and M. Cranor, Secretory carcinoma of the breast, Arch Pathol Lab Med, vol.115, issue.2, pp.141-145, 1991.

T. Krausz, D. Jenkins, and O. Grontoft, Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis, Histopathology, vol.9, issue.1, pp.25-36, 1989.
DOI : 10.1002/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8

H. Oberman, Secretory carcinoma of the breast in adults, The American Journal of Surgical Pathology, vol.4, issue.5, pp.465-70, 1980.
DOI : 10.1097/00000478-198010000-00006

M. Akhtar, C. Robinson, and M. Ali, Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature, Cancer, vol.99, issue.12, pp.2245-54, 1983.
DOI : 10.1002/1097-0142(19830615)51:12<2245::AID-CNCR2820511216>3.0.CO;2-I

D. Horowitz, C. Sharma, and E. Connolly, Secretory carcinoma of the breast: Results from the survival, epidemiology and end results database, The Breast, vol.21, issue.3, pp.350-353, 2012.
DOI : 10.1016/j.breast.2012.02.013

D. Li, X. Xiao, and W. Yang, Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature, Modern Pathology, vol.87, issue.4, pp.567-75, 2012.
DOI : 10.1007/s00404-010-1669-9

R. Diallo, K. Schaefer, and A. Bankfalvi, Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry, Human Pathology, vol.34, issue.12, pp.1299-305, 2003.
DOI : 10.1016/S0046-8177(03)00423-4

M. Laé, P. Fréneaux, and X. Sastre-garau, Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum, Mod Pathol Off J U S Can Acad Pathol Inc, vol.22, issue.2, pp.291-299, 2009.

T. Osako, K. Takeuchi, and R. Horii, Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis, Histopathology, vol.7, issue.4, pp.509-528, 2013.
DOI : 10.1111/his.12172

J. Reis-filho, R. Natrajan, and R. Vatcheva, Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6???split apart??? probes, Histopathology, vol.7, issue.7, pp.840-846, 2008.
DOI : 10.1002/gcc.20200

C. Tognon, S. Knezevich, and D. Huntsman, Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma, Cancer Cell, vol.2, issue.5, pp.367-76, 2002.
DOI : 10.1016/S1535-6108(02)00180-0

S. Knezevich, D. Mcfadden, and W. Tao, A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nature Genetics, vol.2, issue.2, pp.184-191, 1998.
DOI : 10.1006/abio.1987.9999

C. Ramachandran, S. Melnick, and E. Escalon, Cytogenetic and Molecular Characterization of a Congenital Mesoblastic Nephroma, Pediatric and Developmental Pathology, vol.4, issue.4, pp.402-413, 2001.
DOI : 10.1007/s10024001-0034-1

S. Henno, L. Loeuillet, and C. Henry, Cellular Mesoblastic Nephroma: Morphologic, Cytogenetic and Molecular Links with Congenital Fibrosarcoma, Pathology - Research and Practice, vol.199, issue.1, pp.35-40, 2003.
DOI : 10.1078/0344-0338-00350

S. Knezevich, M. Garnett, and T. Pysher, ETV6-NTRK3 Gene Fusions and Trisomy 11 Establish a Histogenetic Link between Mesoblastic Nephroma and Congenital Fibrosarcoma, Cancer Res, vol.58, issue.22, pp.5046-5054, 1998.

M. Eguchi, M. Eguchi-ishimae, and A. Tojo, Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25), Blood, vol.93, issue.4, pp.1355-63, 1999.

M. Setoyama, A. Tojo, and F. Nagamura, A unique translocation of the TEL gene in a case of acute myelogenous leukemia with inv(12)(p13q15), Blood, vol.92, issue.4, pp.1454-1459, 1998.

J. Kralik, W. Kranewitter, and H. Boesmueller, Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia, Diagnostic Pathology, vol.6, issue.1, p.19, 2011.
DOI : 10.1128/MCB.24.11.4636-4650.2004

A. Skálová, T. Vanecek, and R. Sima, Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity, Am J Surg Pathol, vol.34, issue.5, pp.599-608, 2010.

J. Bishop, R. Yonescu, and D. Batista, Most Nonparotid ???Acinic Cell Carcinomas??? Represent Mammary Analog Secretory Carcinomas, The American Journal of Surgical Pathology, vol.37, issue.7, pp.1053-1060, 2013.
DOI : 10.1097/PAS.0b013e3182841554

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686973

J. Bishop and M. Unmasking, Unmasking MASC: Bringing to Light the Unique Morphologic, Immunohistochemical and Genetic Features of the Newly Recognized Mammary Analogue Secretory Carcinoma of Salivary Glands, Head and Neck Pathology, vol.105, issue.1, pp.35-44, 2013.
DOI : 10.1007/s12105-013-0429-0

L. Schwartz, S. Begum, and W. Westra, GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms, Head and Neck Pathology, vol.20, issue.4, pp.311-316, 2013.
DOI : 10.1007/s12105-013-0442-3

S. Brandt, A. Swistel, and P. Rosen, Secretory Carcinoma in the Axilla, The American Journal of Surgical Pathology, vol.33, issue.6, pp.950-953, 2009.
DOI : 10.1097/PAS.0b013e31819c2628

D. Kazakov, M. Hantschke, and T. Vanecek, Mammary-type Secretory Carcinoma of the Skin, The American Journal of Surgical Pathology, vol.34, issue.8, pp.1226-1233, 2010.
DOI : 10.1097/PAS.0b013e3181e4f49d

D. Euhus, C. Timmons, and G. Tomlinson, ETV6-NTRK3???Trk-ing the primary event in human secretory breast cancer, Cancer Cell, vol.2, issue.5, pp.347-355, 2002.
DOI : 10.1016/S1535-6108(02)00184-8

N. Makretsov, M. He, and M. Hayes, A fluorescence in situ hybridization study ofETV6-NTRK3 fusion gene in secretory breast carcinoma, Genes, Chromosomes and Cancer, vol.25, issue.2, pp.152-159, 2004.
DOI : 10.1002/gcc.20028

A. Letessier, C. Ginestier, and E. Charafe-jauffret, ETV6 gene rearrangements in invasive breast carcinoma, Genes, Chromosomes and Cancer, vol.23, issue.1, pp.103-111, 2005.
DOI : 10.1002/gcc.20200

D. Braekeleer, E. Douet-guilbert, N. Morel, and F. , ETV6 fusion genes in hematological malignancies: A review, Leukemia Research, vol.36, issue.8, pp.945-61, 2012.
DOI : 10.1016/j.leukres.2012.04.010

L. Wang, W. Swat, and Y. Fujiwara, The TEL/ETV6 gene is required specifically for hematopoiesis in the bone??marrow, Genes & Development, vol.12, issue.15, pp.2392-402, 1998.
DOI : 10.1101/gad.12.15.2392

M. Edel, The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-cells, Anticancer Res, vol.18, issue.6A, pp.4505-4514, 1998.

T. Golub, G. Barker, and M. Lovett, Fusion of PDGF receptor ?? to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation, Cell, vol.77, issue.2, pp.307-323, 1994.
DOI : 10.1016/0092-8674(94)90322-0

M. Barbacid, The Trk family of neurotrophin receptors, Journal of Neurobiology, vol.159, issue.11, pp.1386-403, 1994.
DOI : 10.1002/neu.480251107

C. Lannon and P. Sorensen, ETV6???NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages, Seminars in Cancer Biology, vol.15, issue.3, pp.215-238, 2005.
DOI : 10.1016/j.semcancer.2005.01.003

C. Tognon, M. Martin, and A. Moradian, A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation, Oncogene, vol.48, issue.10, pp.1334-1374, 2012.
DOI : 10.1038/onc.2011.323

C. Tognon, A. Somasiri, and V. Evdokimova, ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway, Cancer Research, vol.71, issue.3, pp.1060-70, 2011.
DOI : 10.1158/0008-5472.CAN-10-3096

P. Dubus, J. Coindre, and A. Groppi, The detection of Tel-TrkC chimeric transcripts is more specific than TrkC immunoreactivity for the diagnosis of congenital fibrosarcoma, The Journal of Pathology, vol.278, issue.1, pp.88-94, 2001.
DOI : 10.1002/1096-9896(2000)9999:9999<::AID-PATH724>3.0.CO;2-S

H. Chi, B. Ly, and Y. Kano, ETV6???NTRK3 as a therapeutic target of small molecule inhibitor PKC412, Biochemical and Biophysical Research Communications, vol.429, issue.1-2, pp.87-92, 2012.
DOI : 10.1016/j.bbrc.2012.10.087

M. Lambros, D. Tan, and R. Jones, Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication, Journal of Clinical Pathology, vol.62, issue.7, pp.604-616, 2009.
DOI : 10.1136/jcp.2008.059675

M. Hammond, D. Hayes, and M. Dowsett, American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.16, pp.2784-95, 2010.
DOI : 10.1200/JCO.2009.25.6529

A. Wolff, M. Hammond, and D. Hicks, Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013.
DOI : 10.1200/JCO.2013.50.9984

P. Lagarde, G. Pérot, and A. Kauffmann, Mitotic Checkpoints and Chromosome Instability Are Strong Predictors of Clinical Outcome in Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.18, issue.3, pp.826-864, 2012.
DOI : 10.1158/1078-0432.CCR-11-1610

K. Yorozuya, E. Takahashi, and J. Kousaka, A Case of Estrogen Receptor Positive Secretory Carcinoma in a 9-Year-old Girl With ETV6-NTRK3 Fusion Gene, Japanese Journal of Clinical Oncology, vol.42, issue.3, pp.208-219, 2012.
DOI : 10.1093/jjco/hyr187

M. Wong, A. Jara-lazaro, H. Ng, and R. , ETV6 Disruption Does Not Predict Indolent Clinical Behavior in Secretory Breast Carcinoma, The Breast Journal, vol.18, issue.6, pp.604-610, 2012.
DOI : 10.1111/tbj.12041

C. Arce, D. Cortes-padilla, and D. Huntsman, Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature, World Journal of Surgical Oncology, vol.3, issue.1, p.35, 2005.
DOI : 10.1186/1477-7819-3-35

J. Ding, L. Jiang, and Y. Gan, A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis, Int J Clin Exp Pathol, vol.8, issue.3, pp.3322-3329, 2015.

N. Din, R. Idrees, and S. Fatima, Secretory carcinoma of breast: clinicopathologic study of 8 cases, Annals of Diagnostic Pathology, vol.17, issue.1, pp.54-61, 2013.
DOI : 10.1016/j.anndiagpath.2012.06.001

M. Fathi, M. Joudi, and Y. Rajabnejad, Case report: Secretory breast cancer in an 11-year-old girl, Journal of Pediatric Surgery Case Reports, vol.1, issue.10, pp.357-365, 2013.
DOI : 10.1016/j.epsc.2013.09.008

S. Gabal and S. Talaat, Secretory Carcinoma of Male Breast: Case Report and Review of the Literature, International Journal of Breast Cancer, vol.9, issue.4, pp.1-5, 2011.
DOI : 10.1002/gcc.20028

F. Grabellus, K. Worm, and A. Willruth, ETV6???NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual, The Breast, vol.14, issue.1, pp.71-75, 2005.
DOI : 10.1016/j.breast.2004.04.005

S. Matsushima, M. Mori, and Y. Adachi, S100 protein positive human breast carcinomas: An immunohistochemical study, Journal of Surgical Oncology, vol.34, issue.2, pp.108-121, 1994.
DOI : 10.1002/jso.2930550210

P. Anderson, C. Albarracin, E. A. Resetkova, and . Large, Fungating Breast Mass, Disponible sur, 2009.

N. Costa, H. Rodrigues, and H. Pereira, Secretory breast carcinoma???case report and review of the medical literature, The Breast, vol.13, issue.4, pp.353-358, 2004.
DOI : 10.1016/j.breast.2004.01.005

H. Herz, B. Cooke, and D. Goldstein, Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature, Annals of Oncology, vol.11, issue.10, pp.1343-1350, 2000.
DOI : 10.1023/A:1008387800525

A. Kavalakat, R. Covilakam, and T. Culas, Secretory carcinoma of breast in a 17-year-old male, World Journal of Surgical Oncology, vol.2, issue.1, p.17, 2004.
DOI : 10.1186/1477-7819-2-17

S. Vieni, D. Cabibi, and C. Cipolla, Secretory breast carcinoma with metastatic sentinel lymph node, World Journal of Surgical Oncology, vol.4, issue.1, p.88, 2006.
DOI : 10.1186/1477-7819-4-88

A. Skálová, T. Vanecek, and H. Majewska, Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation, The American Journal of Surgical Pathology, vol.38, issue.1, pp.23-33, 2014.
DOI : 10.1097/PAS.0000000000000088

M. Krohn, G. Trams, and G. Brandt, Das sekretorische Mammakarzinom, Geburtshilfe und Frauenheilkunde, vol.49, issue.03, pp.299-301, 1989.
DOI : 10.1055/s-2008-1035759

M. Hill, D. Constenla, A. Hern, and R. , Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma, Oral Oncology, vol.33, issue.4, pp.275-283, 1997.
DOI : 10.1016/S0964-1955(97)00026-2

G. Woto-gaye, A. Kasse, and Y. Dieye, Carcinome s??cr??toire du sein chez l???homme, Annales de Pathologie, vol.24, issue.5, pp.432-437, 2004.
DOI : 10.1016/S0242-6498(04)93999-5

R. Mcdivitt and F. Stewart, Breast carcinoma in children, JAMA, vol.195, pp.144-146, 1966.

V. Eusebi, S. Ichihara, and A. Vincent-salomon, Secretory carcinoma. WHO Classification of Tumors of the Breast, Lyon: IARC, vol.2012, pp.71-72

D. Li, X. Xiao, and W. Yang, Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature, Modern Pathology, vol.87, issue.4, pp.567-575, 2012.
DOI : 10.1007/s00404-010-1669-9

. Lae´mlae´m, P. Fre´neauxfre´neaux, and X. Sastre-garau, Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basallike carcinoma spectrum, Mod Pathol, vol.22, pp.291-298, 2009.

C. Tognon, S. Knezevich, and D. Huntsman, Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma, Cancer Cell, vol.2, issue.5, pp.367-376, 2002.
DOI : 10.1016/S1535-6108(02)00180-0

S. Knezevich, D. Madden, and W. Tao, A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nature Genetics, vol.2, issue.2, pp.184-187, 1998.
DOI : 10.1006/abio.1987.9999

C. Ramachandran, S. Melnick, and E. Escalon, Cytogenetic and Molecular Characterization of a Congenital Mesoblastic Nephroma, Pediatric and Developmental Pathology, vol.4, issue.4, pp.402-411, 2001.
DOI : 10.1007/s10024001-0034-1

M. Eguchi, M. Eguchi-ishimae, and A. Tojo, Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25), Blood, vol.93, pp.1355-1363, 1999.

. Skaíova´skaíova´a, T. Vanecek, and R. Sima, Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity, Am J Surg Pathol, vol.34, pp.599-608, 2010.

J. Bishop, R. Yonescu, and D. Batista, Most non-parotid " acinic cell carcinomas " represent mammary analog secretory carcinomas
DOI : 10.1097/pas.0b013e3182841554

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686973

L. Schwartz, S. Begum, and W. Westra, GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms, Head and Neck Pathology, vol.20, issue.4, pp.311-315, 2013.
DOI : 10.1007/s12105-013-0442-3

C. Tognon, A. Somasiri, and V. Evdokimova, ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway, Cancer Research, vol.71, issue.3, pp.1060-1070, 2011.
DOI : 10.1158/0008-5472.CAN-10-3096

R. Diallo, K. Schaefer, and A. Bankflavi, Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry, Human Pathology, vol.34, issue.12, pp.1299-1304, 2003.
DOI : 10.1016/S0046-8177(03)00423-4

M. Lambros, D. Tan, and R. Jones, Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication, Journal of Clinical Pathology, vol.62, issue.7, pp.604-612, 2009.
DOI : 10.1136/jcp.2008.059675

M. Hammond, D. Hayes, and M. Dowsett, American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.16, pp.2784-2795, 2010.
DOI : 10.1200/JCO.2009.25.6529

A. Wolff, M. Hammond, and D. Hicks, Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013.
DOI : 10.1200/JCO.2013.50.9984

P. Lagarde, G. Perot, and A. Kauffmann, Mitotic Checkpoints and Chromosome Instability Are Strong Predictors of Clinical Outcome in Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.18, issue.3, pp.826-838, 2012.
DOI : 10.1158/1078-0432.CCR-11-1610

C. Curtis, P. Shah, S. Chin, and S. , The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, pp.346-352, 2013.
DOI : 10.1038/nature10983

S. Knezevich, M. Garnett, and T. Pysher, ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma, Cancer Res, vol.58, pp.5046-5048, 1998.

. Skaíova´skaíova´a, T. Vanecek, and H. Majewska, Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, b-catenin, EGFR, and CCND1 genes, Am J Surg Pathol, vol.38, pp.23-33, 2014.

D. Horowitz, C. Sharma, and E. Connolly, Secretory carcinoma of the breast: Results from the survival, epidemiology and end results database, The Breast, vol.21, issue.3, pp.350-353, 2012.
DOI : 10.1016/j.breast.2012.02.013

M. Wong, A. Jara-lazaro, H. Ng, and R. , ETV6 Disruption Does Not Predict Indolent Clinical Behavior in Secretory Breast Carcinoma, The Breast Journal, vol.18, issue.6, pp.604-606, 2012.
DOI : 10.1111/tbj.12041

C. Arce, D. Cortes-padilla, and D. Huntsman, Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature, World Journal of Surgical Oncology, vol.3, issue.1, p.35, 2005.
DOI : 10.1186/1477-7819-3-35

G. Woto-gaye, A. Kasse, and Y. Dieye, Carcinome s??cr??toire du sein chez l???homme, Annales de Pathologie, vol.24, issue.5, pp.432-435, 2004.
DOI : 10.1016/S0242-6498(04)93999-5